ArticleFrontiers in pharmacology2024

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway.

Hao Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.